Emily Blood - Concepedia

Author

Emily Blood

Boston Children's Hospital

Also Known As

Carey, Timothy S., E Blood, E. Blood, Emily A Blood, Emily A. Blood, Emily Blood

137

Publications

12.8K

Citations

H-Index

166

Concepts

All Affiliations

Boston Children's Hospital Harvard University Dana-Farber Cancer Institute Dartmouth College Mayo Clinic in Arizona

About

Emily Blood is an author at Boston Children's Hospital specializing in medicine, health sciences, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	27	2K
2	Health Sciences	14	14	1K
3	Education	3	3	260
4	Nursing	2	2	121
5	Arts	1	1	22

Emily Blood

Publications

12.6K

Citations

H-Index

Page 1

	Year	Citations
Surgical versus Nonsurgical Therapy for Lumbar Spinal Stenosis James N. Weinstein, Tor D. Tosteson, Jon D. Lurie, New England Journal of Medicine	2008	1.2K
Surgical versus Nonsurgical Treatment for Lumbar Degenerative Spondylolisthesis James N. Weinstein, Jon D. Lurie, Tor D. Tosteson, New England Journal of Medicine	2007	926
Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group S. Vincent Rajkumar, Emily Blood, David H. Vesole, Journal of Clinical Oncology	2005	871
Surgical Versus Nonoperative Treatment for Lumbar Disc Herniation James N. Weinstein, Jon D. Lurie, Tor D. Tosteson, Spine	2008	710
Clinical and biologic implications of recurrent genomic aberrations in myeloma Rafaël Fonseca, Emily Blood, Montserrat Rué, Blood	2003	658
Surgical Compared with Nonoperative Treatment for Lumbar Degenerative Spondylolisthesis James N. Weinstein, Jon D. Lurie, Tor D. Tosteson, Journal of Bone and Joint Surgery	2009	613
Surgical Versus Nonoperative Treatment for Lumbar Spinal Stenosis Four-Year Results of the Spine Patient Outcomes Research Trial James N. Weinstein, Tor D. Tosteson, Jon D. Lurie, Spine	2010	569
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma Paul G. Richardson, Emily Blood, Constantine S. Mitsiades, Blood	2006	520
Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients Rafaël Fonseca, Emily Blood, Martin M. Oken, Blood	2002	337
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients Lynda C. Schneider, Rima Rachid, Jennifer LeBovidge, Journal of Allergy and Clinical Immunology AsthmaHigh-risk Peanut-allergic PatientsFood AllergyAllergyAllergy Medicine	2013	297

Page 1